GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Short-Term Capital Lease Obligation

Piramal Pharma (NSE:PPLPHARMA) Short-Term Capital Lease Obligation : ₹333 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Short-Term Capital Lease Obligation?

Piramal Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹333 Mil.

Piramal Pharma's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (₹349 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹333 Mil).

Piramal Pharma's annual Short-Term Capital Lease Obligation increased from Mar. 2022 (₹184 Mil) to Mar. 2023 (₹304 Mil) and increased from Mar. 2023 (₹304 Mil) to Mar. 2024 (₹333 Mil).

Piramal Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Piramal Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Short-Term Capital Lease Obligation Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Short-Term Capital Lease Obligation
16.90 184.40 303.90 333.10

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 303.90 - 348.60 - 333.10

Piramal Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Piramal Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
BOM:533573 BOM:524816 BOM:543064 BOM:506820 BOM:540596 BOM:500126 BOM:540222 BOM:532482 BOM:524742 BOM:543322 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
543635:India
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Website
https://www.piramal.com
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines